A longitudinal, prospective, multicenter observational study in patients with rheumatoid arthritis receiving tocilizumab

A longitudinal, prospective, multicenter observational study in patients with rheumatoid arthritis receiving tocilizumab - Michinoku tocilizumab study

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000011584

Enrollment

500

Registered

2013-08-27

Start date

2010-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rheumatoid Arthritis

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: The patients with rheumatoid arthritis receiving tocilizumab

Exclusion criteria

Exclusion criteria: Not applicable

Design outcomes

Primary

Measure	Time frame
DAS28ESR, CRP, adverse effect, persistency	—

Secondary

Measure	Time frame
WBC, RBC, Hb, PLT, AST, ALT, Cr, Total-cho, TG, HDL-cho, MMP-3, joint roentgenogram	—

Countries

Japan

Contacts

Public ContactYasuhiko Hirabayashi

Hikarigaoka Spellman Hospital Department of Rheumatology

mr.hirabayashi@gmail.com022-257-0231

Outcome results